FLT3 and acute myeloid leukemia: Somatic mutations in ML–DS patients most frequently affect cohesin complex genes, JAK family kinases, and epigenetic regulators, but mutations frequently observed in AML, such as FLT3 or TP53 mutations, can also be found (Table 1) (26–28).